OLUTASIDENIB for Brain neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where OLUTASIDENIB was used for Brain neoplasm malignant.
Most Reported Side Effects for OLUTASIDENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 59 | 28.1% | 3 | 18 |
| Hospitalisation | 27 | 12.9% | 3 | 27 |
| Death | 24 | 11.4% | 24 | 6 |
| Nausea | 23 | 11.0% | 0 | 11 |
| Fatigue | 21 | 10.0% | 1 | 7 |
| Product dose omission issue | 19 | 9.1% | 1 | 6 |
| Product prescribing issue | 15 | 7.1% | 0 | 5 |
| Constipation | 14 | 6.7% | 1 | 7 |
| Transfusion | 11 | 5.2% | 1 | 4 |
| Pneumonia | 9 | 4.3% | 2 | 9 |
| Asthenia | 7 | 3.3% | 0 | 2 |
| Dyspnoea | 7 | 3.3% | 0 | 2 |
| Product use issue | 7 | 3.3% | 2 | 1 |
| Rash | 7 | 3.3% | 1 | 3 |
| Vomiting | 7 | 3.3% | 0 | 2 |
Other Indications for OLUTASIDENIB
Acute myeloid leukaemia (119)
Acute myeloid leukaemia refractory (19)
Myelodysplastic syndrome (14)
Product used for unknown indication (8)
Myelodysplastic syndrome with excess blasts (5)
Other Drugs Used for Brain neoplasm malignant
PROCARBAZINE (2,283)
TEMOZOLOMIDE (2,202)
BEVACIZUMAB (740)
TRAMETINIB DIMETHYL SULFOXIDE (317)
LOMUSTINE (291)
THALIDOMIDE (195)
DABRAFENIB (189)
IVOSIDENIB (140)
SELINEXOR (136)
AVAPRITINIB (122)